These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 32111969

  • 1. CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm.
    Bôle-Richard E, Fredon M, Biichlé S, Anna F, Certoux JM, Renosi F, Tsé F, Molimard C, Valmary-Degano S, Jenvrin A, Warda W, Pallandre JR, Bonnefoy F, Poussard M, Deschamps M, Petrella T, Roumier C, Macintyre E, Féger F, Brissot E, Mohty M, HoWangYin KY, Langlade-Demoyen P, Loustau M, Caumartin J, Godet Y, Binda D, Pagadoy M, Deconinck E, Daguindau E, Saas P, Ferrand C, Angelot-Delettre F, Adotévi O, Garnache-Ottou F.
    Leukemia; 2020 Dec; 34(12):3228-3241. PubMed ID: 32111969
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Xue T, Budde LE.
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):575-587. PubMed ID: 32336421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia.
    El Khawanky N, Hughes A, Yu W, Myburgh R, Matschulla T, Taromi S, Aumann K, Clarson J, Vinnakota JM, Shoumariyeh K, Miething C, Lopez AF, Brown MP, Duyster J, Hein L, Manz MG, Hughes TP, White DL, Yong ASM, Zeiser R.
    Nat Commun; 2021 Nov 08; 12(1):6436. PubMed ID: 34750374
    [Abstract] [Full Text] [Related]

  • 10. Targeting CD123 in BPDCN: an emerging field.
    DiPippo AJ, Wilson NR, Pemmaraju N.
    Expert Rev Hematol; 2021 Nov 08; 14(11):993-1004. PubMed ID: 34607517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Bôle-Richard E, Pemmaraju N, Caël B, Daguindau E, Lane AA.
    Cancers (Basel); 2022 May 03; 14(9):. PubMed ID: 35565416
    [Abstract] [Full Text] [Related]

  • 13. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD.
    Am J Surg Pathol; 2019 Oct 03; 43(10):1429-1437. PubMed ID: 31261288
    [Abstract] [Full Text] [Related]

  • 14. Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia.
    Arcangeli S, Rotiroti MC, Bardelli M, Simonelli L, Magnani CF, Biondi A, Biagi E, Tettamanti S, Varani L.
    Mol Ther; 2017 Aug 02; 25(8):1933-1945. PubMed ID: 28479045
    [Abstract] [Full Text] [Related]

  • 15. Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation.
    Jiang YL, Li Q, Yuan T, Jiang YY, Deng Q.
    Onco Targets Ther; 2020 Aug 02; 13():3425-3430. PubMed ID: 32368098
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AML.
    Meyer JE, Loff S, Dietrich J, Spehr J, Jurado Jiménez G, von Bonin M, Ehninger G, Cartellieri M, Ehninger A.
    Oncoimmunology; 2021 Aug 02; 10(1):1945804. PubMed ID: 34290907
    [Abstract] [Full Text] [Related]

  • 17. Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia.
    Tasian SK, Kenderian SS, Shen F, Ruella M, Shestova O, Kozlowski M, Li Y, Schrank-Hacker A, Morrissette JJD, Carroll M, June CH, Grupp SA, Gill S.
    Blood; 2017 Apr 27; 129(17):2395-2407. PubMed ID: 28246194
    [Abstract] [Full Text] [Related]

  • 18. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Kerr D, Zhang L, Sokol L.
    Curr Treat Options Oncol; 2019 Feb 04; 20(1):9. PubMed ID: 30715612
    [Abstract] [Full Text] [Related]

  • 19. Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm.
    Tandon A, Zhang Y, Sokol L.
    Drugs Today (Barc); 2019 Dec 04; 55(12):735-742. PubMed ID: 31942876
    [Abstract] [Full Text] [Related]

  • 20. CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.
    Testa U, Pelosi E, Castelli G.
    Cancers (Basel); 2019 Sep 12; 11(9):. PubMed ID: 31547472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.